| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |